FRNM · Freenome, Inc. · Metrics
$14.37
-0.42 (-2.84%)
At close · Sep 11
Going-concern doubt
— flagged Jul 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company's liquidity condition and mandatory liquidation raise substantial doubt about the Company's ability to continue as a going concern for a period of time within one year after the date that the accompanying unaudited condensed consolidated financial statements are issued. Management plans to address this uncertainty through a Business Combination. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after the Combination Period. The Company intends to complete the initial Business Combination before the end of the Combination Period. However, there can be no assurance that the Company will be able to consummate any Business Combination by the end of the Combination Period, including if the combination Period is further extended upon approval of the Extension Amendment Proposal.”View the 10-Q filed Jul 15, 2026
Market Cap
$148.20M
Shares
10.31M
FRNM metrics
43 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$14.37
Market cap
$148.20M
Price action
20 metricsPrice change (1W)
-12.5%
Price change (30D)
+27.4%
Price change (3M)
+31.2%
Price change (6M)
+32.3%
Price change (YTD)
+13.5%
Price change (1Y)
+40.2%
Trailing year
Price change (5Y)
—
52-week high
$16.90
52-week low
$9.99
Change from 52-week high
-12.5%
Change from 52-week low
+48.0%
Annualized volatility
41.9%
Annualized volatility (3M)
60.9%
Beta
0.4
RSI (14D)
56.8
Price vs SMA 50
+17.8%
Price vs SMA 200
+22.1%
Avg volume (3M)
594,282
Relative volume
1.3
Average dollar volume
$7.57M
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
10.31M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-0.5%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$4.33M
Net income (TTM)
−$762,626
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
-115.2%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-0.9%
Debt / equity
—
Current ratio
0.2
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$437,369
Latest balance sheet
Cash & equivalents
$437,369
Total assets
$85.83M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$907,040
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
27
13F filer change QoQ
-7
Institutional ownership
85.3%
Short interest
3 metricsShort interest
14.8%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
67 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged